US2004253622A1PendingUtilityA1
Androgen regulated prostate specific polypeptide-5 (ARP-5)
Est. expiryMar 28, 2021(expired)· nominal 20-yr term from priority
Inventors:Biaoyang Lin
C12Q 1/6886C12Q 2600/136Y10S530/821
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides novel androgen regulated nucleic acid molecules. Related polypeptides and diagnostic methods also are provided.
Claims
exact text as granted — not AI-modified1 . to 61 . Canceled.
62 . A substantially pure ARP5 polypeptide, comprising substantially an amino acid sequence having at least 40% amino acid identity with SEQ ID No:9.
63 . The substantially pure ARP5 polypeptide of claim 62 , comprising the amino acid sequence shown as SEQ ID NO:9.
64 . A substantially pure ARP5 polypeptide fragment, comprising at least eight contiguous amino acids of SEQ ID NO:9.
65 to 71 . CanceledCited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.